Allergic Rhinitis
Conditions
Interventions
Control group 1:Mometasone furoate nasal spray
Control group 2:Mometasone furoate nasal Spray Combined with Traditional Chinese Medicine Fumigation (Xiaoqinglong Decoction)
Treatment group:Mometasone furoate nasal spray combined with traditional Chinese medicine fumigation (Xiaoqinglong decoction) and sharp crochet needle
Control group 3:Mometasone furoate nasal spray combined with a sharp crochet needle
Sponsors
Guangzhou University of Chinese Medicine First Affiliated Hospital Chongqing Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) The age of 18-80 years old gender is not limited; 2) Meet the diagnostic criteria of allergic rhinitis; 3) Those who meet the standard of TCM syndrome differentiation of lung Qi deficiency cold type; (4) Patients who have not received drug treatment or related treatment within 2 weeks of onset; 5) be conscious and voluntarily sign informed consent; 6) Willing to actively cooperate with the test and complete the return visit on time; 7) Meet the above conditions can be included.
Exclusion criteria
Exclusion criteria: 1) Combined with pulmonary infection drug rhinitis eosinophilia and other diseases; (2) Patients with severe zangfu organ dysfunction liver and kidney dysfunction hematopoietic system dysfunction and other serious systemic diseases; 3) Patients with autoimmune diseases and other respiratory diseases (such as tuberculosis emphysema etc.); (4) Patients with mental diseases who are not awake and cannot cooperate; (5) in the pregnancy or breastfeeding period; 6) Participate in multiple (=2) clinical trials during the study period; 7) Patients with drug allergy in this study program; 8) Those who meet any of the above criteria cannot be included in the group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum interleukin 13;Serum interferon ?;Serum immunoglobulin E;serum thymic stromal lymphopoietin;serum interleukin 4;Total Nasal Symptom Score;serum interleukin 5;Nasal concomitant symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Rhinoconjunctivitis quality of life questionnaire score;color of nasal mucosa;Nasal secretions eosinophils;Signs score;Visual analogue scale scale; | — |
Countries
China
Contacts
Public ContactTao long
Guangzhou University of Chinese Medicine First Affiliated Hospital Chongqing Hospital
Outcome results
None listed